Literature DB >> 8923837

Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates.

R E Ostlund1, J W Yang, S Klein, R Gingerich.   

Abstract

We measured plasma leptin concentrations by RIA in 204 normal weight and obese subjects, aged 18-80 yr, using full-length recombinant human leptin as a standard. Fasting levels between 1.2-97.9 ng/mL were observed. The plasma leptin concentration was highly correlated with percent body fat (r = 0.710; P < 0.0001) and was 3 times as high in women as in men (17.1 vs. 5.8 ng/mL; P < 0.0001). Circulating leptin was inversely related to age and was reduced 53% in subjects over age 60 yr. A statistical model containing percent body fat, gender, and age accounted for 65% of the variance in plasma leptin levels. Leptin was not independently related to abdominal fat distribution, plasma lipids and lipoproteins, chronic energy intake, diet composition, plasma insulin, or maximum oxygen consumption. However, plasma leptin was reduced by 26% in 5 obese subjects who consumed a 1000-Cal diet for 10 days (P = 0.004). We conclude that circulating leptin rises continuously with increasing adiposity. Gender, age, and short term caloric restriction may be important secondary regulators of plasma leptin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923837     DOI: 10.1210/jcem.81.11.8923837

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  115 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Relation between leptin and body fat distribution in menopausal status.

Authors:  P A Martínez-Carpio; C Fiol; I Hurtado; C Arias; E Ruiz; P Orozco; A Corominas
Journal:  J Physiol Biochem       Date:  2003-12       Impact factor: 4.158

3.  Clinical and biochemical parameters in relation to serum leptin levels in South Indian children and adolescents.

Authors:  Srinivasa Nageswara Rao; G Prema Gurumurthy; Priya Gururajan; Sarasa Barathi Arumugam; V Kirthivasan; K M Cherian
Journal:  Indian J Pediatr       Date:  2010-04-17       Impact factor: 1.967

Review 4.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

5.  Contribution of androgens to the gender difference in leptin production in obese children and adolescents.

Authors:  M Wabitsch; W F Blum; R Muche; M Braun; F Hube; W Rascher; E Heinze; W Teller; H Hauner
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

6.  Impact of hypoalphalipoproteinemia on quality of life in Taiwanese women with central obesity.

Authors:  I-Ju Chen; Wei-Chun Lin; Chia-Yu Liu; You-Lung Song; Jung-Peng Chiu; Chung-Hua Hsu
Journal:  Qual Life Res       Date:  2013-12-10       Impact factor: 4.147

Review 7.  Multifaceted leptin network: the molecular connection between obesity and breast cancer.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-11-10       Impact factor: 2.673

8.  Leptin levels in patients with type 1 diabetes receiving intensive insulin therapy compared with those in patients receiving conventional insulin therapy.

Authors:  S T Azar; P A Zalloua; M S Zantout; C H Shahine; I Salti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

9.  Dynamic responses to leptin secretagogues in lean, obese, and massively obese men and women.

Authors:  Samuel Dagogo-Jack; Hasan Askari; Gunjan Tykodi; Jianmei Liu; Indira Umamaheswaran
Journal:  Horm Res       Date:  2008-07-29

Review 10.  Role of adipocytokines in predicting the development of diabetes and its late complications.

Authors:  Nese Ersoz Gulcelik; Aydan Usman; Alper Gürlek
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.